FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4476911000001109: Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18181301000001114 Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
106646201000001115 Cisplatin 50mg/50ml concentrate for solution for infusion vials (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Is a Cisplatin 50mg/50ml solution for injection vials true Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Has active ingredient Cisplatin true Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Has specific active ingredient Cisplatin true Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) 1 vial Is pack of False Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) 1 vial Has AMP True Cisplatin 50mg/50ml solution for injection vials (Mayne Pharma Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start